- Home
- AVDL vs FLNC Comparison
AVDL vs FLNC Comparison
Compare AVDL & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- FLNC
- Stock Information
- Founded
- AVDL 2015
- FLNC 2018
- Country
- AVDL Ireland
- FLNC United States
- Employees
- AVDL N/A
- FLNC N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- FLNC Industrial Machinery/Components
- Sector
- AVDL Health Care
- FLNC Miscellaneous
- Exchange
- AVDL Nasdaq
- FLNC Nasdaq
- Market Cap
- AVDL 861.4M
- FLNC 802.6M
- IPO Year
- AVDL 1996
- FLNC 2021
- Fundamental
- Price
- AVDL $10.04
- FLNC $7.94
- Analyst Decision
- AVDL Strong Buy
- FLNC Hold
- Analyst Count
- AVDL 6
- FLNC 18
- Target Price
- AVDL $18.17
- FLNC $8.81
- AVG Volume (30 Days)
- AVDL 1.6M
- FLNC 6.3M
- Earning Date
- AVDL 08-07-2025
- FLNC 08-06-2025
- Dividend Yield
- AVDL N/A
- FLNC N/A
- EPS Growth
- AVDL N/A
- FLNC N/A
- EPS
- AVDL N/A
- FLNC N/A
- Revenue
- AVDL $194,450,000.00
- FLNC $2,329,871,000.00
- Revenue This Year
- AVDL $56.88
- FLNC $2.61
- Revenue Next Year
- AVDL $29.81
- FLNC $27.01
- P/E Ratio
- AVDL N/A
- FLNC N/A
- Revenue Growth
- AVDL 252.64
- FLNC 6.08
- 52 Week Low
- AVDL $6.38
- FLNC $3.46
- 52 Week High
- AVDL $17.30
- FLNC $24.00
- Technical
- Relative Strength Index (RSI)
- AVDL 63.41
- FLNC 65.19
- Support Level
- AVDL $8.74
- FLNC $6.06
- Resistance Level
- AVDL $9.56
- FLNC $8.92
- Average True Range (ATR)
- AVDL 0.40
- FLNC 0.59
- MACD
- AVDL 0.08
- FLNC 0.11
- Stochastic Oscillator
- AVDL 98.70
- FLNC 70.32
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.